Investing
Top Analyst Upgrades and Downgrades (AMLN, NLY, ARMH, BBBY, CO, DPS, LVLT, SANM, YHOO)
Published:
Last Updated:
These are this Thursday’s top analyst upgrades, downgrades, and initiations seen from Wall Street morning research calls:
Amylin Pharmaceuticals (NASDAQ: AMLN) Started as Buy at Merriman Curhan Ford.
Annaly Mortgage (NYSE: NLY) Cut to Market Perform at JMP Securities.
ARM Holdings (NASDAQ: ARMH) Cut to Hold ar RBS.
Bed Bath & Beyond (NASDAQ: BBBY) Cut to Underperform at FBR Capital.
China Cord Blood Corporation (NYSE: CO) Started as Buy at Roth Capital.
Dr Pepper Snapple (NYSE: DPS) Raised to Buy at UBS.
Level 3 Communications (NASDAQ: LVLT) Raised to Neutral at JPMorgan.
Sanmina-SCI (NASDAQ: SANM) Started as Hold at Collins Stewart.
Yahoo ! Inc. (NASDAQ: YHOO) Cut to Hold at Benchmark.
You can join our free daily email distribution list to hear more about dividend trends, analyst upgrades and downgrades, top day trader and active trader alerts, news on Buffett and other investment gurus, IPOs, secondary offerings, private equity, and more.
JON C. OGG
Want to Retire Early? Start Here (Sponsor)
Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Have questions about retirement or personal finance? Email us at [email protected]!
By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.
By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
